| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |